ProfileGDS5678 / 1459712_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 51% 48% 48% 48% 57% 52% 59% 48% 47% 47% 48% 47% 53% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2745951
GSM967853U87-EV human glioblastoma xenograft - Control 23.1395348
GSM967854U87-EV human glioblastoma xenograft - Control 33.1454348
GSM967855U87-EV human glioblastoma xenograft - Control 43.0882348
GSM967856U87-EV human glioblastoma xenograft - Control 53.3954257
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3543352
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6147659
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1341548
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0829547
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1041747
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1439448
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.075147
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2956453
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1368148